Researcher

Zhongyu Lu

State Key Laboratory of Neurology and Oncology Drug Development, Jiangsu Simcere Diagnostics Co., Ltd., Nanjing Simcere Medical Laboratory Science Co., Ltd., Nanjing, China.

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

JUL 14, 2026 · JOURNAL ARTICLE

xinguangA preliminary characterization of PI4K/PIPK alterations across solid tumors: an exploratory framework for prognostic and therapeutic stratification.

Cancer Biology & Therapy

Exploratory retrospective analysis identifying genomic alteration patterns and associations, requiring prospective validation before clinical implementation.

PreliminarySolid Tumors Xinguang Han Zhongyu Lu

Reported

Sample size2,144

Tumor types analyzed18

PI4K/PIPK alteration frequency10.5%